Literature DB >> 8461612

DNA ploidy, c-myc oncoprotein p62 and v-H-ras oncoprotein p21 in colorectal carcinoma.

T Teranishi1, K Matsumoto, N Ishijima, T Miura, H Suzuki.   

Abstract

DNA ploidy and expression of the c-myc oncoprotein p62 and the v-H-ras oncoprotein p21 were examined in 54 colorectal carcinomas. DNA ploidy, determined by DNA flow cytometry, was diploid in 19 samples and aneuploid in 35. Expression of the p62 oncoprotein, determined by immunohistochemical staining, was intensely positive in 18 samples while that of the p21 oncoprotein, also determined by immunohistochemical staining, was positive in 29. There was no correlation between DNA ploidy and expression of the p62 oncoprotein, and DNA ploidy did not correlate with expression of the p21 oncoprotein. There was, however, a close correlation between expression of the p62 oncoprotein and that of the p21 oncoprotein being P < 0.01 according to Peason's chi-square test.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461612     DOI: 10.1007/bf00309008

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

1.  Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.

Authors:  S Rowley; K M Newbold; J Gearty; M R Keighley; I A Donovan; J P Neoptolemos
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

2.  General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum.

Authors: 
Journal:  Jpn J Surg       Date:  1983-11

3.  The influence of tumour cell DNA abnormalities on survival in colorectal cancer.

Authors:  N C Armitage; R A Robins; D F Evans; D R Turner; R W Baldwin; J D Hardcastle
Journal:  Br J Surg       Date:  1985-10       Impact factor: 6.939

4.  DNA distribution in human colon carcinomas and its relationship to clinical behavior.

Authors:  R C Wolley; K Schreiber; L G Koss; M Karas; A Sherman
Journal:  J Natl Cancer Inst       Date:  1982-07       Impact factor: 13.506

5.  Flow cytometry of colorectal carcinoma with three-year follow-up.

Authors:  M R Melamed; W E Enker; P Banner; A J Janov; G Kessler; Z Darzynkiewicz
Journal:  Dis Colon Rectum       Date:  1986-03       Impact factor: 4.585

6.  DNA ploidy of colorectal carcinoma. Correlation with conventional prognostic variables.

Authors:  H Suzuki; K Matsumoto; T Masuda; H Koike
Journal:  J Clin Gastroenterol       Date:  1988-04       Impact factor: 3.062

7.  Tumor DNA content in the prognosis of colorectal carcinoma.

Authors:  W Kokal; K Sheibani; J Terz; J R Harada
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.